Minimum inhibitory concentration, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring: An integrated approach for multidrug-resistant tuberculosis

by Shashikant Srivastava
Published 2015-01-01

Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating Mycobacterium tuberculosis

by Shashikant Srivastava, Shashikant Srivastava, Shashikant Srivastava, Kayle N. Cirrincione, Devyani Deshpande, Tawanda Gumbo, Tawanda Gumbo, Tawanda Gumbo
Published 2021-01-01

Effect of specimen processing, growth supplement, and different metabolic population on Mycobacterium tuberculosis laboratory diagnosis.

by Shashikant Srivastava, Moti Chapagain, Tawanda Gumbo
Published 2020-01-01

Comparison of Rifamycins for Efficacy Against Mycobacterium avium Complex and Resistance Emergence in the Hollow Fiber Model System

by Gunavanthi D. Boorgula, Laxmi U. M. R. Jakkula, Tawanda Gumbo, Bockgie Jung, Shashikant Srivastava, Shashikant Srivastava
Published 2021-04-01

Potency of vancomycin against Mycobacterium tuberculosis in the hollow fiber system model

by Shashikant Srivastava, Moti Chapagain, Johanna van Zyl, Devyani Deshpande, Tawanda Gumbo
Published 2021-03-01

Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis

by Shashikant Srivastava, Shashikant Srivastava, Tania Thomas, Dave Howe, Lesibana Malinga, Prithvi Raj, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Tawanda Gumbo, Tawanda Gumbo
Published 2021-06-01

Mycobacterium tuberculosis sterilizing activity of faropenem, pyrazinamide and linezolid combination and failure to shorten the therapy duration

by Tawanda Gumbo, Carleton M. Sherman, Devyani Deshpande, Jan-Willem Alffenaar, Shashikant Srivastava
Published 2021-03-01

Redox Imbalance and Oxidative DNA Damage During Isoniazid Treatment of HIV-Associated Tuberculosis: A Clinical and Translational Pharmacokinetic Study

by Isaac Zentner, Hyun-moon Back, Leonid Kagan, Selvakumar Subbian, Jyothi Nagajyothi, Shashikant Srivastava, Jotam Pasipanodya, Tawanda Gumbo, Gregory P. Bisson, Christopher Vinnard
Published 2020-07-01

Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation.

by Christopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, Jotam Pasipanodya, Shashikant Srivastava, Chawangwa Modongo, Nicola M Zetola, Drew Weissman, Tawanda Gumbo, Gregory P Bisson
Published 2017-01-01

Urine colorimetry for therapeutic drug monitoring of pyrazinamide during tuberculosis treatment

by Isaac Zentner, Chawangwa Modongo, Nicola M. Zetola, Jotam G. Pasipanodya, Shashikant Srivastava, Scott K. Heysell, Stellah Mpagama, Hans P. Schlect, Tawanda Gumbo, Gregory P. Bisson, Christopher Vinnard
Published 2018-03-01

sncRNA-1 Is a Small Noncoding RNA Produced by Mycobacterium tuberculosis in Infected Cells That Positively Regulates Genes Coupled to Oleic Acid Biosynthesis

by Fatma S. Coskun, Shashikant Srivastava, Prithvi Raj, Igor Dozmorov, Serkan Belkaya, Smriti Mehra, Nadia A. Golden, Allison N. Bucsan, Moti L. Chapagain, Edward K. Wakeland, Deepak Kaushal, Deepak Kaushal, Tawanda Gumbo, Nicolai S. C. van Oers, Nicolai S. C. van Oers, Nicolai S. C. van Oers
Published 2020-07-01